NCT01358227View on ClinicalTrials.gov

A Phase I Dose Escalation Trial of PR104 Given Weekly in Subjects With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

December 31, 2009

Study Completion Date

January 31, 2010

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

PR104

Dose escalation of PR104 to determine maximum tolerated dose for weekly administration

Trial Locations (2)

Unknown

University of Auckland, Auckland

Waikato Hospital, Waikato

All Listed Sponsors
lead

Proacta, Incorporated

INDUSTRY

NCT01358227 - A Phase I Dose Escalation Trial of PR104 Given Weekly in Subjects With Solid Tumors | Biotech Hunter | Biotech Hunter